Search clinical trials for: bupropion extended release (Wellbutrin XL)

Total 887 results

Mylan Pharmaceuticals Inc

Completed

Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers

Healthy

United States
In His Image
Kos Pharmaceuticals

Completed

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

Dyslipidemia | Hyperlipidemia | Mixed Hyperlipidemia

United States
Abbott

Terminated

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Bipolar Disorder

United States
Christopher Patrick Smith

Unknown

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Overactive Bladder

United States
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Pain | Tumor

Austria, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Italy, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, Slovakia, Spain, Sweden
Medical College of Wisconsin

Recruiting

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Brain Metastases

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
University at Buffalo
AstraZeneca

Completed

An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

Evaluate Ketogenic Stress

United States
Anu Sharma

Terminated

Propranolol in Treating Hypoglycemia Unawareness

Type 1 Diabetes Mellitus

United States
Cephalon

Completed

A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment

Renal Impairment

United States
The Baruch Padeh Medical Center, Poriya

Terminated

Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery

Preterm Labor
Bristol-Myers Squibb

Completed

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

HIV Infections | AIDS

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer
Lei Lei, MD

Recruiting

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. (ADHD)

Attention Deficit Disorder With Hyperactivity | Executive Function Disorder

China
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy

United States
Mayo Clinic

Completed

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Obesity

United States
University of North Carolina, Chapel Hill
Flexion Therapeutics, Inc.

Completed

Effect of Zilretta Injection

Osteoarthritis, Knee

United States
Shire

Completed

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Colitis, Ulcerative

Belgium
Danish Headache Center

Completed

Multiomics After Headache Provocation of People Who Are Unable to Have Headache

Healthy | Headache

Denmark
Adamas Pharmaceuticals, Inc.

Completed

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Parkinson's Disease (PD) | Dyskinesia | Levodopa Induced Dyskinesia (LID)

France, Spain, United States, Canada, Germany, Austria
The University of Texas Health Science Center,...
The Center for Clinical and Translational Sciences (CCTS) Clinical Research...

Completed

Effects of Antidiabetic Medications on the Postprandial State in Prediabetes

Obesity | Prediabetes

United States
Adamas Pharmaceuticals, Inc.

Completed

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) (EASE LID)

Parkinson's Disease | Dyskinesia | Levodopa Induced Dyskinesia (LID)

United States, Canada
University of Minnesota
GlaxoSmithKline

Completed

Determination of Absorption and Elimination of Lamotrigine-XR

Epilepsy | Bipolar Disorder | Seizures | Bipolar Depression

United States
Novartis Pharmaceuticals

Completed

A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions

Healthy

India
New York State Psychiatric Institute

Completed

Treatment of Depression Following Multiple Brain Tests

Major Depression | Dysthymia

United States
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Enrolling by invitation

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Opioid Use Disorder

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Wake Forest University Health Sciences

Withdrawn

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Opioid Use
Anders Fink-Jensen, MD, DMSci
The Novavì outpatient clinics, Copenhagen; Neurobiology Research Unit, Rigshospitalet... and other collaborators

Completed

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence? (EXALT)

Addiction, Alcohol | Alcohol Dependence, in Remission

Denmark
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Plaque Inflammation and Dysfunctional HDL in AIM-HIGH (HDL Proteomics)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Atherosclerosis

United States, Canada
McGill University Health Centre/Research Institute...
CIHR Canadian HIV Trials Network

Completed

Niacin on Immune Activation : a Proof-of-concept Study

HIV

Canada
Adamas Pharmaceuticals, Inc.

Completed

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (EASED)

Parkinson's Disease | Dyskinesia | Levodopa Induced Dyskinesia

United States
Alkermes, Inc.

Completed

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

Alcoholism
Mayo Clinic

Completed

Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels

Roux-en-Y Gastric Bypass | Gastric Bypass | Bariatric Surgery

United States
Johnson & Johnson Pharmaceutical Research & Development...
Grünenthal GmbH

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy

United States, Canada, Puerto Rico
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg

Healthy

United States
ANRS, Emerging Infectious Diseases

Not yet recruiting

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. (CABOPrEP)

Prevention

France
University of Kansas Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Individualizing Pharmacotherapy for African American Smokers

Smoking Cessation

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease

Cerebrovascular Disorders | Smoking Cessation

Canada
University of Washington

Unknown

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

Substance-Related Disorders

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

Major Depressive Disorder

United States
Adamas Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Multiple Sclerosis | Walking Impairment

United States, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

Low Back Pain

United States
GlaxoSmithKline

Completed

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

Epilepsy

United States

Search clinical trials for: bupropion extended release (Wellbutrin XL)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations